Transce3nd LLC acquired a new position in The Allstate Co. (NYSE:ALL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,945 shares of the insurance provider's stock, valued at approximately $568,000.
Several other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in shares of Allstate by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock valued at $6,291,783,000 after acquiring an additional 389,426 shares during the period. Geode Capital Management LLC grew its holdings in Allstate by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider's stock valued at $1,236,060,000 after purchasing an additional 191,147 shares during the period. GQG Partners LLC increased its position in Allstate by 64.1% in the fourth quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock worth $832,181,000 after buying an additional 1,685,694 shares in the last quarter. Invesco Ltd. raised its stake in shares of Allstate by 3.0% in the fourth quarter. Invesco Ltd. now owns 3,681,306 shares of the insurance provider's stock worth $709,719,000 after buying an additional 106,730 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Allstate by 1.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,834,172 shares of the insurance provider's stock valued at $353,610,000 after buying an additional 19,463 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.
Insider Transactions at Allstate
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.80% of the company's stock.
Allstate Trading Up 0.2 %
ALL stock opened at $194.61 on Friday. The firm has a market cap of $51.58 billion, a PE ratio of 11.45, a price-to-earnings-growth ratio of 1.01 and a beta of 0.36. The firm has a fifty day moving average price of $197.27 and a 200 day moving average price of $194.37. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The Allstate Co. has a fifty-two week low of $156.66 and a fifty-two week high of $212.91.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. Sell-side analysts anticipate that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.
Allstate announced that its board has initiated a stock buyback program on Wednesday, February 26th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the insurance provider to buy up to 3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's management believes its shares are undervalued.
Allstate Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a dividend of $1.00 per share. The ex-dividend date was Monday, March 10th. This is an increase from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a yield of 2.06%. Allstate's dividend payout ratio is 23.54%.
Analyst Upgrades and Downgrades
ALL has been the topic of a number of recent analyst reports. StockNews.com cut shares of Allstate from a "buy" rating to a "hold" rating in a research note on Friday. JPMorgan Chase & Co. raised their price objective on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. Argus raised shares of Allstate from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. Keefe, Bruyette & Woods decreased their price target on Allstate from $240.00 to $228.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, Evercore ISI upgraded Allstate from an "in-line" rating to an "outperform" rating in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $219.27.
Get Our Latest Report on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.